🍽🦠 PubMed Studies Citing Bacteria Shifts for (2E,4E)-5-(1,3-Benzodioxol-5-yl)-1-(1-piperidinyl)-2,4-pentadien-1-one {Piperine} - Escherichia coli O6:K2:H1

Citations are updated once a week. Recently added citations may not appear.

3 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
(2E,4E)-5-(1,3-Benzodioxol-5-yl)-1-(1-piperidinyl)-2,4-pentadien-1-one {Piperine} - Escherichia coli O6:K2:H1    👶 The Effect of Black Pepper (Piperine) Extract Supplementation on Growth Performance, Nutrient Digestibility, Fecal Microbial, Fecal Gas Emission, and Meat Quality of Finishing Pigs.
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 10 Issue 11 Pages:
Pub: 2020 Oct 25 Epub: 2020 Oct 25 Authors Sampath V , Shanmugam S , Park JH , Kim IH ,
Html Article Publication
(2E,4E)-5-(1,3-Benzodioxol-5-yl)-1-(1-piperidinyl)-2,4-pentadien-1-one {Piperine} - Escherichia coli O6:K2:H1    👶 Piperine, an active ingredient of white pepper, suppresses the growth of multidrug-resistant toxigenic Vibrio cholerae and other pathogenic bacteria.
Letters in applied microbiology (Lett Appl Microbiol ) Vol: 74 Issue 4 Pages: 472-481
Pub: 2022 Apr Epub: 2022 Feb 8 Authors Manjunath GB , Awasthi SP , Zahid MSH , Hatanaka N , Hinenoya A , Iwaoka E , Aoki S , Ramamurthy T , Yamasaki S ,
Publication
(2E,4E)-5-(1,3-Benzodioxol-5-yl)-1-(1-piperidinyl)-2,4-pentadien-1-one {Piperine} - Escherichia coli O6:K2:H1    👶 Synthesis, in vitro and in silico anti-bacterial analysis of piperine and piperic ester analogues.
Chemical biology & drug design (Chem Biol Drug Des ) Vol: 98 Issue 1 Pages: 19-29
Pub: 2021 Jul Epub: 2021 Apr 21 Authors Sivashanmugam A , Velmathi S ,
Publication

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]